Skip to main content
PMC home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1993 Jan;56(1):6–16. doi: 10.1136/jnnp.56.1.6

Current management of ischaemic stroke.

R S Marshall 1, J P Mohr 1
PMCID: PMC1014757  PMID: 8429324

Full text

PDF
6

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abbott R. D., Yin Y., Reed D. M., Yano K. Risk of stroke in male cigarette smokers. N Engl J Med. 1986 Sep 18;315(12):717–720. doi: 10.1056/NEJM198609183151201. [DOI] [PubMed] [Google Scholar]
  2. Acheson J., Danta G., Hutchinson E. C. Controlled trial of dipyridamole in cerebral vascular disease. Br Med J. 1969 Mar 8;1(5644):614–615. doi: 10.1136/bmj.1.5644.614. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Adams H. P., Jr, Gross C. E. Embolism distal to stenosis of the middle cerebral artery. Stroke. 1981 Mar-Apr;12(2):228–229. doi: 10.1161/01.str.12.2.228. [DOI] [PubMed] [Google Scholar]
  4. Albers G. W. Role of ticlopidine for prevention of stroke. Stroke. 1992 Jun;23(6):912–916. doi: 10.1161/01.str.23.6.912. [DOI] [PubMed] [Google Scholar]
  5. Albers G. W., Sherman D. G., Gress D. R., Paulseth J. E., Petersen P. Stroke prevention in nonvalvular atrial fibrillation: a review of prospective randomized trials. Ann Neurol. 1991 Oct;30(4):511–518. doi: 10.1002/ana.410300402. [DOI] [PubMed] [Google Scholar]
  6. Bamford J., Sandercock P., Jones L., Warlow C. The natural history of lacunar infarction: the Oxfordshire Community Stroke Project. Stroke. 1987 May-Jun;18(3):545–551. doi: 10.1161/01.str.18.3.545. [DOI] [PubMed] [Google Scholar]
  7. Barnett H. J., Peerless S. J., Kaufmann J. C. "Stump" on internal carotid artery--a source for further cerebral embolic ischemia. Stroke. 1978 Sep-Oct;9(5):448–456. doi: 10.1161/01.str.9.5.448. [DOI] [PubMed] [Google Scholar]
  8. Beal M. F., Williams R. S., Richardson E. P., Jr, Fisher C. M. Cholesterol embolism as a cause of transient ischemic attacks and cerebral infarction. Neurology. 1981 Jul;31(7):860–865. doi: 10.1212/wnl.31.7.860. [DOI] [PubMed] [Google Scholar]
  9. Biller J., Love B. B., Marsh E. E., 3rd, Jones M. P., Knepper L. E., Jiang D., Adams H. P., Jr, Gordon D. L. Spontaneous improvement after acute ischemic stroke. A pilot study. Stroke. 1990 Jul;21(7):1008–1012. doi: 10.1161/01.str.21.7.1008. [DOI] [PubMed] [Google Scholar]
  10. Bogousslavsky J., Cachin C., Regli F., Despland P. A., Van Melle G., Kappenberger L. Cardiac sources of embolism and cerebral infarction--clinical consequences and vascular concomitants: the Lausanne Stroke Registry. Neurology. 1991 Jun;41(6):855–859. doi: 10.1212/wnl.41.6.855. [DOI] [PubMed] [Google Scholar]
  11. Bogousslavsky J., Van Melle G., Regli F. The Lausanne Stroke Registry: analysis of 1,000 consecutive patients with first stroke. Stroke. 1988 Sep;19(9):1083–1092. doi: 10.1161/01.str.19.9.1083. [DOI] [PubMed] [Google Scholar]
  12. Bousser M. G., Eschwege E., Haguenau M., Lefaucconnier J. M., Thibult N., Touboul D., Touboul P. J. "AICLA" controlled trial of aspirin and dipyridamole in the secondary prevention of athero-thrombotic cerebral ischemia. Stroke. 1983 Jan-Feb;14(1):5–14. doi: 10.1161/01.str.14.1.5. [DOI] [PubMed] [Google Scholar]
  13. Boysen G., Sørensen P. S., Juhler M., Andersen A. R., Boas J., Olsen J. S., Joensen P. Danish very-low-dose aspirin after carotid endarterectomy trial. Stroke. 1988 Oct;19(10):1211–1215. doi: 10.1161/01.str.19.10.1211. [DOI] [PubMed] [Google Scholar]
  14. Briley D. P., Coull B. M., Goodnight S. H., Jr Neurological disease associated with antiphospholipid antibodies. Ann Neurol. 1989 Mar;25(3):221–227. doi: 10.1002/ana.410250303. [DOI] [PubMed] [Google Scholar]
  15. Brott T. G., Haley E. C., Jr, Levy D. E., Barsan W., Broderick J., Sheppard G. L., Spilker J., Kongable G. L., Massey S., Reed R. Urgent therapy for stroke. Part I. Pilot study of tissue plasminogen activator administered within 90 minutes. Stroke. 1992 May;23(5):632–640. doi: 10.1161/01.str.23.5.632. [DOI] [PubMed] [Google Scholar]
  16. Caplan L. R., Brass L. M., DeWitt L. D., Adams R. J., Gomez C., Otis S., Weschler L. R., von Reutern G. M. Transcranial Doppler ultrasound: present status. Neurology. 1990 Apr;40(4):696–700. doi: 10.1212/wnl.40.4.696. [DOI] [PubMed] [Google Scholar]
  17. Carpenter D. A., Grubb R. L., Jr, Powers W. J. Borderzone hemodynamics in cerebrovascular disease. Neurology. 1990 Oct;40(10):1587–1592. doi: 10.1212/wnl.40.10.1587. [DOI] [PubMed] [Google Scholar]
  18. Castaigne P., Lhermitte F., Gautier J. C., Escourolle R., Derouesné C., Der Agopian P., Popa C. Arterial occlusions in the vertebro-basilar system. A study of 44 patients with post-mortem data. Brain. 1973;96(1):133–154. doi: 10.1093/brain/96.1.133. [DOI] [PubMed] [Google Scholar]
  19. Chalmers A. C., Greco C. M., Miller R. G. Prognosis in AZT myopathy. Neurology. 1991 Aug;41(8):1181–1184. doi: 10.1212/wnl.41.8.1181. [DOI] [PubMed] [Google Scholar]
  20. Chamorro A., Sacco R. L., Mohr J. P., Foulkes M. A., Kase C. S., Tatemichi T. K., Wolf P. A., Price T. R., Hier D. B. Clinical-computed tomographic correlations of lacunar infarction in the Stroke Data Bank. Stroke. 1991 Feb;22(2):175–181. doi: 10.1161/01.str.22.2.175. [DOI] [PubMed] [Google Scholar]
  21. Chodosh E. H., Foulkes M. A., Kase C. S., Wolf P. A., Mohr J. P., Hier D. B., Price T. R., Furtado J. G., Jr Silent stroke in the NINCDS Stroke Data Bank. Neurology. 1988 Nov;38(11):1674–1679. doi: 10.1212/wnl.38.11.1674. [DOI] [PubMed] [Google Scholar]
  22. Choi D. W. Cerebral hypoxia: some new approaches and unanswered questions. J Neurosci. 1990 Aug;10(8):2493–2501. doi: 10.1523/JNEUROSCI.10-08-02493.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Collins R., Peto R., MacMahon S., Hebert P., Fiebach N. H., Eberlein K. A., Godwin J., Qizilbash N., Taylor J. O., Hennekens C. H. Blood pressure, stroke, and coronary heart disease. Part 2, Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet. 1990 Apr 7;335(8693):827–838. doi: 10.1016/0140-6736(90)90944-z. [DOI] [PubMed] [Google Scholar]
  24. DAVID N. J., KLINTWORTH G. K., FRIEDBERG S. J., DILLON M. FETAL ATHEROMATOUS CEREBRAL EMBOLISM ASSOCIATED WITH BRIGHT PLAQUES IN THE RETINAL ARTERIOLES. REPORT OF A CASE. Neurology. 1963 Aug;13:708–713. doi: 10.1212/wnl.13.8.708. [DOI] [PubMed] [Google Scholar]
  25. Davis P. H., Dambrosia J. M., Schoenberg B. S., Schoenberg D. G., Pritchard D. A., Lilienfeld A. M., Whisnant J. P. Risk factors for ischemic stroke: a prospective study in Rochester, Minnesota. Ann Neurol. 1987 Sep;22(3):319–327. doi: 10.1002/ana.410220307. [DOI] [PubMed] [Google Scholar]
  26. Dawson T. M., Dawson V. L., Snyder S. H. A novel neuronal messenger molecule in brain: the free radical, nitric oxide. Ann Neurol. 1992 Sep;32(3):297–311. doi: 10.1002/ana.410320302. [DOI] [PubMed] [Google Scholar]
  27. DeWitt L. D., Wechsler L. R. Transcranial Doppler. Stroke. 1988 Jul;19(7):915–921. doi: 10.1161/01.str.19.7.915. [DOI] [PubMed] [Google Scholar]
  28. Duke R. J., Bloch R. F., Turpie A. G., Trebilcock R., Bayer N. Intravenous heparin for the prevention of stroke progression in acute partial stable stroke. Ann Intern Med. 1986 Dec;105(6):825–828. doi: 10.7326/0003-4819-105-6-825. [DOI] [PubMed] [Google Scholar]
  29. EASTCOTT H. H., PICKERING G. W., ROB C. G. Reconstruction of internal carotid artery in a patient with intermittent attacks of hemiplegia. Lancet. 1954 Nov 13;267(6846):994–996. doi: 10.1016/s0140-6736(54)90544-9. [DOI] [PubMed] [Google Scholar]
  30. FISHER C. M. LACUNES: SMALL, DEEP CEREBRAL INFARCTS. Neurology. 1965 Aug;15:774–784. doi: 10.1212/wnl.15.8.774. [DOI] [PubMed] [Google Scholar]
  31. Fields W. S., Lemak N. A., Frankowski R. F., Hardy R. J. Controlled trial of aspirin in cerebral ischemia. Stroke. 1977 May-Jun;8(3):301–314. doi: 10.1161/01.str.8.3.301. [DOI] [PubMed] [Google Scholar]
  32. Fisher C. M., Pearlman A. The nonsudden onset of cerebral embolism. Neurology. 1967 Nov;17(11):1025–1032. doi: 10.1212/wnl.17.11.1025. [DOI] [PubMed] [Google Scholar]
  33. Foulkes M. A., Wolf P. A., Price T. R., Mohr J. P., Hier D. B. The Stroke Data Bank: design, methods, and baseline characteristics. Stroke. 1988 May;19(5):547–554. doi: 10.1161/01.str.19.5.547. [DOI] [PubMed] [Google Scholar]
  34. Gent M., Blakely J. A., Easton J. D., Ellis D. J., Hachinski V. C., Harbison J. W., Panak E., Roberts R. S., Sicurella J., Turpie A. G. The Canadian American Ticlopidine Study (CATS) in thromboembolic stroke. Lancet. 1989 Jun 3;1(8649):1215–1220. doi: 10.1016/s0140-6736(89)92327-1. [DOI] [PubMed] [Google Scholar]
  35. Gill J. S., Zezulka A. V., Shipley M. J., Gill S. K., Beevers D. G. Stroke and alcohol consumption. N Engl J Med. 1986 Oct 23;315(17):1041–1046. doi: 10.1056/NEJM198610233151701. [DOI] [PubMed] [Google Scholar]
  36. Gillum R. F., Fabsitz R. R., Feinleib M., Wolf P. A., Margolis J. R., Brasch R. C. Community surveillance for cerebrovascular disease: the Framingham Cardiovascular Disease Survey. Public Health Rep. 1978 Sep-Oct;93(5):438–442. [PMC free article] [PubMed] [Google Scholar]
  37. Goldstein L. B., Perry A. Early recurrent ischemic stroke. A case-control study. Stroke. 1992 Jul;23(7):1010–1013. doi: 10.1161/01.str.23.7.1010. [DOI] [PubMed] [Google Scholar]
  38. Gordon D. L., Linhardt R., Adams H. P., Jr Low-molecular-weight heparins and heparinoids and their use in acute or progressing ischemic stroke. Clin Neuropharmacol. 1990 Dec;13(6):522–543. doi: 10.1097/00002826-199012000-00005. [DOI] [PubMed] [Google Scholar]
  39. Grolimund P., Seiler R. W., Aaslid R., Huber P., Zurbruegg H. Evaluation of cerebrovascular disease by combined extracranial and transcranial Doppler sonography. Experience in 1,039 patients. Stroke. 1987 Nov-Dec;18(6):1018–1024. doi: 10.1161/01.str.18.6.1018. [DOI] [PubMed] [Google Scholar]
  40. Grotta J. C., Norris J. W., Kamm B. Prevention of stroke with ticlopidine: who benefits most? TASS Baseline and Angiographic Data Subgroup. Neurology. 1992 Jan;42(1):111–115. doi: 10.1212/wnl.42.1.111. [DOI] [PubMed] [Google Scholar]
  41. Guiraud-Chaumeil B., Rascol A., David J., Boneu B., Clanet M., Bierme R. Prévention des récidives des accidents vasculaires cérébraux ischémiques par les anti-agrégants plaquettaires. Résultats d'un essai thérapeutique contrôlé de 3 ans. Rev Neurol (Paris) 1982;138(5):367–385. [PubMed] [Google Scholar]
  42. Hacke W., Zeumer H., Ferbert A., Brückmann H., del Zoppo G. J. Intra-arterial thrombolytic therapy improves outcome in patients with acute vertebrobasilar occlusive disease. Stroke. 1988 Oct;19(10):1216–1222. doi: 10.1161/01.str.19.10.1216. [DOI] [PubMed] [Google Scholar]
  43. Haley E. C., Jr, Levy D. E., Brott T. G., Sheppard G. L., Wong M. C., Kongable G. L., Torner J. C., Marler J. R. Urgent therapy for stroke. Part II. Pilot study of tissue plasminogen activator administered 91-180 minutes from onset. Stroke. 1992 May;23(5):641–645. doi: 10.1161/01.str.23.5.641. [DOI] [PubMed] [Google Scholar]
  44. Hass W. K., Easton J. D., Adams H. P., Jr, Pryse-Phillips W., Molony B. A., Anderson S., Kamm B. A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. Ticlopidine Aspirin Stroke Study Group. N Engl J Med. 1989 Aug 24;321(8):501–507. doi: 10.1056/NEJM198908243210804. [DOI] [PubMed] [Google Scholar]
  45. High-dose acetylsalicylic acid after cerebral infarction. A Swedish Cooperative Study. Stroke. 1987 Mar-Apr;18(2):325–334. doi: 10.1161/01.str.18.2.325. [DOI] [PubMed] [Google Scholar]
  46. Hommel M., Besson G., Le Bas J. F., Gaio J. M., Pollak P., Borgel F., Perret J. Prospective study of lacunar infarction using magnetic resonance imaging. Stroke. 1990 Apr;21(4):546–554. doi: 10.1161/01.str.21.4.546. [DOI] [PubMed] [Google Scholar]
  47. Jonas S. Anticoagulant therapy in cerebrovascular disease: review and meta-analysis. Stroke. 1988 Aug;19(8):1043–1048. doi: 10.1161/01.str.19.8.1043. [DOI] [PubMed] [Google Scholar]
  48. Kiyohara Y., Ueda K., Hasuo Y., Fujii I., Yanai T., Wada J., Kawano H., Shikata T., Omae T., Fujishima M. Hematocrit as a risk factor of cerebral infarction: long-term prospective population survey in a Japanese rural community. Stroke. 1986 Jul-Aug;17(4):687–692. doi: 10.1161/01.str.17.4.687. [DOI] [PubMed] [Google Scholar]
  49. Lechat P., Mas J. L., Lascault G., Loron P., Theard M., Klimczac M., Drobinski G., Thomas D., Grosgogeat Y. Prevalence of patent foramen ovale in patients with stroke. N Engl J Med. 1988 May 5;318(18):1148–1152. doi: 10.1056/NEJM198805053181802. [DOI] [PubMed] [Google Scholar]
  50. Levin S. M., Sondheimer F. K., Levin J. M. The contralateral diseased but asymptomatic carotid artery: to operate or not? An update. Am J Surg. 1980 Aug;140(2):203–205. doi: 10.1016/0002-9610(80)90005-7. [DOI] [PubMed] [Google Scholar]
  51. Masuda J., Ogata J., Yutani C., Miyashita T., Yamaguchi T. Artery-to-artery embolism from a thrombus formed in stenotic middle cerebral artery. Report of an autopsy case. Stroke. 1987 May-Jun;18(3):680–684. doi: 10.1161/01.str.18.3.680. [DOI] [PubMed] [Google Scholar]
  52. Mayberg M. R., Wilson S. E., Yatsu F., Weiss D. G., Messina L., Hershey L. A., Colling C., Eskridge J., Deykin D., Winn H. R. Carotid endarterectomy and prevention of cerebral ischemia in symptomatic carotid stenosis. Veterans Affairs Cooperative Studies Program 309 Trialist Group. JAMA. 1991 Dec 18;266(23):3289–3294. [PubMed] [Google Scholar]
  53. Meehan E. F., Sobel E., Alter M., Francis M. E., McCoy R. L., Levitt L. P. The Lehigh Valley Stroke Program: establishing a communitywide, hospital-based stroke register. Am J Prev Med. 1986 Mar-Apr;2(2):97–102. [PubMed] [Google Scholar]
  54. Mohr J. P., Caplan L. R., Melski J. W., Goldstein R. J., Duncan G. W., Kistler J. P., Pessin M. S., Bleich H. L. The Harvard Cooperative Stroke Registry: a prospective registry. Neurology. 1978 Aug;28(8):754–762. doi: 10.1212/wnl.28.8.754. [DOI] [PubMed] [Google Scholar]
  55. Mori E., Tabuchi M., Yoshida T., Yamadori A. Intracarotid urokinase with thromboembolic occlusion of the middle cerebral artery. Stroke. 1988 Jul;19(7):802–812. doi: 10.1161/01.str.19.7.802. [DOI] [PubMed] [Google Scholar]
  56. Nencini P., Baruffi M. C., Abbate R., Massai G., Amaducci L., Inzitari D. Lupus anticoagulant and anticardiolipin antibodies in young adults with cerebral ischemia. Stroke. 1992 Feb;23(2):189–193. doi: 10.1161/01.str.23.2.189. [DOI] [PubMed] [Google Scholar]
  57. Okada Y., Sadoshima S., Nakane H., Utsunomiya H., Fujishima M. Early computed tomographic findings for thrombolytic therapy in patients with acute brain embolism. Stroke. 1992 Jan;23(1):20–23. doi: 10.1161/01.str.23.1.20. [DOI] [PubMed] [Google Scholar]
  58. Petersen P., Boysen G., Godtfredsen J., Andersen E. D., Andersen B. Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study. Lancet. 1989 Jan 28;1(8631):175–179. doi: 10.1016/s0140-6736(89)91200-2. [DOI] [PubMed] [Google Scholar]
  59. Podore P. C., DeWeese J. A., May A. G., Rob C. G. Asymptomatic contralateral carotid artery stenosis: a five-year follow-up study following carotid endarterectomy. Surgery. 1980 Dec;88(6):748–752. [PubMed] [Google Scholar]
  60. Pokras R., Dyken M. L. Dramatic changes in the performance of endarterectomy for diseases of the extracranial arteries of the head. Stroke. 1988 Oct;19(10):1289–1290. doi: 10.1161/01.str.19.10.1289. [DOI] [PubMed] [Google Scholar]
  61. Rascol A., Clanet M., Manelfe C., Guiraud B., Bonafe A. Pure motor hemiplegia: CT study of 30 cases. Stroke. 1982 Jan-Feb;13(1):11–17. doi: 10.1161/01.str.13.1.11. [DOI] [PubMed] [Google Scholar]
  62. Reuther R., Dorndorf W., Loew D. Behandlung transitorisch-ischämischer Attacken mit Azetylsalizylsäure Ergebnisse einer Doppelblindstudie. MMW Munch Med Wochenschr. 1980 May 23;122(21):795–798. [PubMed] [Google Scholar]
  63. Rothman S. M., Olney J. W. Glutamate and the pathophysiology of hypoxic--ischemic brain damage. Ann Neurol. 1986 Feb;19(2):105–111. doi: 10.1002/ana.410190202. [DOI] [PubMed] [Google Scholar]
  64. Sacco R. L., Ellenberg J. H., Mohr J. P., Tatemichi T. K., Hier D. B., Price T. R., Wolf P. A. Infarcts of undetermined cause: the NINCDS Stroke Data Bank. Ann Neurol. 1989 Apr;25(4):382–390. doi: 10.1002/ana.410250410. [DOI] [PubMed] [Google Scholar]
  65. Sacco R. L., Hauser W. A., Mohr J. P. Hospitalized stroke in blacks and Hispanics in northern Manhattan. Stroke. 1991 Dec;22(12):1491–1496. doi: 10.1161/01.str.22.12.1491. [DOI] [PubMed] [Google Scholar]
  66. Sacco R. L., Owen J., Mohr J. P., Tatemichi T. K., Grossman B. A. Free protein S deficiency: a possible association with cerebrovascular occlusion. Stroke. 1989 Dec;20(12):1657–1661. doi: 10.1161/01.str.20.12.1657. [DOI] [PubMed] [Google Scholar]
  67. Sacco R. L., Wolf P. A., Kannel W. B., McNamara P. M. Survival and recurrence following stroke. The Framingham study. Stroke. 1982 May-Jun;13(3):290–295. doi: 10.1161/01.str.13.3.290. [DOI] [PubMed] [Google Scholar]
  68. Schlaepfer W. W., Zimmerman U. J. Mechanisms underlying the neuronal response to ischemic injury. Calcium-activated proteolysis of neurofilaments. Prog Brain Res. 1985;63:185–196. doi: 10.1016/s0079-6123(08)61983-4. [DOI] [PubMed] [Google Scholar]
  69. Simon R. P., Swan J. H., Griffiths T., Meldrum B. S. Blockade of N-methyl-D-aspartate receptors may protect against ischemic damage in the brain. Science. 1984 Nov 16;226(4676):850–852. doi: 10.1126/science.6093256. [DOI] [PubMed] [Google Scholar]
  70. Sorensen P. S., Pedersen H., Marquardsen J., Petersson H., Heltberg A., Simonsen N., Munck O., Andersen L. A. Acetylsalicylic acid in the prevention of stroke in patients with reversible cerebral ischemic attacks. A Danish cooperative study. Stroke. 1983 Jan-Feb;14(1):15–22. [PubMed] [Google Scholar]
  71. Stampfer M. J., Colditz G. A., Willett W. C., Speizer F. E., Hennekens C. H. A prospective study of moderate alcohol consumption and the risk of coronary disease and stroke in women. N Engl J Med. 1988 Aug 4;319(5):267–273. doi: 10.1056/NEJM198808043190503. [DOI] [PubMed] [Google Scholar]
  72. Takano K., Yamaguchi T., Uchida K. Markers of a hypercoagulable state following acute ischemic stroke. Stroke. 1992 Feb;23(2):194–198. doi: 10.1161/01.str.23.2.194. [DOI] [PubMed] [Google Scholar]
  73. Tatemichi T. K., Chamorro A., Petty G. W., Khandji A., Oropeza L. A., Duterte D. I., Mohr J. P. Hemodynamic role of ophthalmic artery collateral in internal carotid artery occlusion. Neurology. 1990 Mar;40(3 Pt 1):461–464. doi: 10.1212/wnl.40.3_part_1.461. [DOI] [PubMed] [Google Scholar]
  74. Taylor D. W., Sackett D. L., Haynes R. B. Sample size for randomized trials in stroke prevention. How many patients do we need? Stroke. 1984 Nov-Dec;15(6):968–971. doi: 10.1161/01.str.15.6.968. [DOI] [PubMed] [Google Scholar]
  75. Wiebers D. O., Adams H. P., Jr, Whisnant J. P. Animal models of stroke: are they relevant to human disease? Stroke. 1990 Jan;21(1):1–3. doi: 10.1161/01.str.21.1.1. [DOI] [PubMed] [Google Scholar]
  76. Wiebers D. O., Adams H. P., Jr, Whisnant J. P. Animal models of stroke: are they relevant to human disease? Stroke. 1990 Jan;21(1):1–3. doi: 10.1161/01.str.21.1.1. [DOI] [PubMed] [Google Scholar]
  77. Wiernsperger N., Gygax P., Hofmann A. Calcium antagonist PY 108-068: demonstration of its efficacy in various types of experimental brain ischemia. Stroke. 1984 Jul-Aug;15(4):679–685. doi: 10.1161/01.str.15.4.679. [DOI] [PubMed] [Google Scholar]
  78. Wolf P. A., D'Agostino R. B., Kannel W. B., Bonita R., Belanger A. J. Cigarette smoking as a risk factor for stroke. The Framingham Study. JAMA. 1988 Feb 19;259(7):1025–1029. [PubMed] [Google Scholar]
  79. Wolf P. A., Dawber T. R., Thomas H. E., Jr, Kannel W. B. Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: the Framingham study. Neurology. 1978 Oct;28(10):973–977. doi: 10.1212/wnl.28.10.973. [DOI] [PubMed] [Google Scholar]
  80. ZATZ L. M., IANNONE A. M., ECKMAN P. B., HECKER S. P. OBSERVATIONS CONCERNING INTRACEREBRAL VASCULAR OCCLUSIONS. Neurology. 1965 Apr;15:389–401. doi: 10.1212/wnl.15.4.389. [DOI] [PubMed] [Google Scholar]
  81. Zanette E. M., Fieschi C., Bozzao L., Roberti C., Toni D., Argentino C., Lenzi G. L. Comparison of cerebral angiography and transcranial Doppler sonography in acute stroke. Stroke. 1989 Jul;20(7):899–903. doi: 10.1161/01.str.20.7.899. [DOI] [PubMed] [Google Scholar]
  82. Zierler R. E., Kohler T. R., Strandness D. E., Jr Duplex scanning of normal or minimally diseased carotid arteries: correlation with arteriography and clinical outcome. J Vasc Surg. 1990 Oct;12(4):447–455. [PubMed] [Google Scholar]
  83. del Zoppo G. J., Poeck K., Pessin M. S., Wolpert S. M., Furlan A. J., Ferbert A., Alberts M. J., Zivin J. A., Wechsler L., Busse O. Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke. Ann Neurol. 1992 Jul;32(1):78–86. doi: 10.1002/ana.410320113. [DOI] [PubMed] [Google Scholar]
  84. von Kummer R., Hacke W. Safety and efficacy of intravenous tissue plasminogen activator and heparin in acute middle cerebral artery stroke. Stroke. 1992 May;23(5):646–652. doi: 10.1161/01.str.23.5.646. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES